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Introduction {#s1}
============

The Global Burden of Disease study demonstrated that smoking continues to exert a significant mortality burden, with worldwide smoking-attributable deaths increasing by 20% since 1990.[@R1] In Australia, following adoption of a series of tobacco control measures,[@R2] age-standardised smoking prevalence decreased from 30.8% to 16.8% from 1980 to 2012.[@R3] However, given population growth, this still represents a substantial number of smokers and a large burden of tobacco-related disease, with \>15 000 Australians projected to succumb to premature tobacco-related death each year.[@R4]

The healthcare costs of tobacco-related morbidity and mortality (ie, the costs of treating smoking-related illnesses in those who smoke) have been well described, with around 15% of healthcare expenditure attributed to smoking in high-income countries.[@R5] However, these direct costs represent only a proportion of the adverse economic impact of tobacco smoking. Indirect costs include second-hand smoke exposure, costs to employers arising from absenteeism and lost productivity due to smoking among their workforce, welfare benefits associated with supporting those with chronic smoking-related illness and smoking-attributable fires. Less readily quantifiable societal burdens include the social and emotional impact of smoking-related mortality and morbidity on family and loved ones. Of the indirect costs, productivity losses are substantial, but often of lower profile. In Australia in the financial year 2004/2005, it was estimated that the productivity losses associated with smoking was \$A8 billion, which far outweighed the \$A1.8 billion in direct healthcare costs of smoking.[@R6]

Price-based tobacco control measures (such as tobacco taxes) have been shown to be the most effective method for reducing tobacco consumption.[@R7] However, tobacco consumption also confers economic benefits, including income generated as a result of the production and consumption of tobacco and tobacco taxes accrued by governments. These counterbalancing financial issues are often raised when governments are considering tobacco control measures.

In order to provide a clearer understanding of the macro-economic impact of productivity loss due to smoking, we undertook a study that uses a novel measure developed by our group, productivity-adjusted life years (PALYs),[@R8] to examine the productivity burden of smoking in a contemporary Australian setting.

Methods {#s2}
=======

We used life table modelling and decision analysis[@R9] to examine the impact of smoking on years of life, quality-adjusted life years (QALYs) and PALYs lived among Australians of working age. PALYs are a construct similar to QALYs, but with years of life lived penalised for time spent with reduced work productivity (instead of reduced quality of life) as a result of ill health.[@R8] Akin to utilities that quantify quality of life, 'productivity indices' represent the productivity of an individual in proportional terms, ranging from 1.0 (100% productive) to 0 (completely non-productive). Productivity indices may change, for example, with age and/or ill health.

Life tables were constructed using age-specific and sex-specific rates of mortality for smoking and non-smoking adults aged 20--69 years, based on the 2016 Australian population (see online [supplementary appendix 1](#SP1){ref-type="supplementary-material"} and [table 1](#T1){ref-type="table"}). The cohorts were followed until death or age 70 years. The 20--69 years age range was chosen to reflect the ages where people are commonly engaged in paid employment. Analyses were then repeated with the smoking cohort assumed to be non-smokers, and years of life, QALYs and PALYs lived were recalculated. The differences in these measures between the two cohort simulations represented the years of life, QALYs and PALYs lost to smoking.
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###### 

Modelled population

  Age group (years)   Males           Females                                  
  ------------------- --------------- --------- ------ --------------- ------- ------
  20--24              851 818         0.162     54.1   807 634         0.173   48.7
  25--29              885 390         0.255     79.7   873 715         0.142   57.2
  30--34              876 875         0.255     79.7   874 000         0.142   57.2
  35--39              785 670         0.222     84.3   790 262         0.141   55.3
  40--44              819 943         0.222     84.3   835 414         0.141   55.3
  45--49              774 379         0.207     78.0   789 310         0.172   56.9
  50--54              769 307         0.207     78.0   788 657         0.172   56.9
  55--59              714 584         0.183     68.2   736 359         0.129   49.2
  60--64              632 862         0.183     52.2   653 546         0.129   33.6
  65--69              570 582         0.111     33.6   582 977         0.069   17.7
  **Total**           **7 681 410**                    **6 924 240**           

\*Australian population at 2015.

†Smoking prevalence data from the Australian National Health Survey 2014--2015.[@R13]

‡Percentage of total EFT workers from Australian workforce participation data.[@R15]

EFT, equivalent full time.

Within each of the smoking and non-smoking cohorts, we created separate life tables with 1 year cycles for 20 sex-and-age subcohorts, with age being stratified into ten 5-year age bands: 20--24, 25--29, 30--34, 35--39, 40--44, 45--49, 50--54, 55--59, 60--64 and 65--69 years. The starting age in each subcohort was assumed as the mid-point of the age group (eg, 22 years for age group 20--24 years, 27 years for age group 25--29 years).

For each sex-age cohort, specific mortality rates (by age, sex and smoking status) were applied, as well as smoking-related utilities derived from health-related quality of life measures[@R10] and productivity indices calculated from previously reported rates of absenteeism and presenteeism in smoking compared with non-smoking workers.[@R11]

Analyses assuming a 10%, 25%, 50%, 75% and 90% reduction in current smoking prevalence rates were also undertaken.

Data sources {#s2a}
------------

Age-specific and sex-specific mortality rates for single-year age bands were obtained from the Australian General Record of Incidence of Mortality data for 2015.[@R12] Smoking prevalence data were drawn from the Australian National Health Survey 2014--2015.[@R13] Probabilities of death for smokers and non-smokers were calculated from mortality risk in the wider population and population-attributable risk percentage (proportion of all deaths occurring in a population that is attributable to smoking) reported by Peto *et al*,[@R14] and extrapolated above and below the age of 35 years using exponential equations for male and female smokers and non-smokers. The sex-specific and age-specific probabilities of death for smokers and non-smokers are listed in online [supplementary appendix 1](#SP1){ref-type="supplementary-material"}.

For the modelling of QALYs, we derived utility decrements due to smoking from a 2010 US study examining trends in health-related quality of life (assessed using the EuroQol 5D (EQ-5D) quality of life tool) associated with smoking by Jia and Lubetkin.[@R10]

Productivity decrements due to smoking were estimated from a study by Bunn *et al* examining productivity loss due to smoking.[@R11] This study found that smokers missed more days at work (absenteeism) (6.7 vs 4.4 days/year) and experienced more unproductive days (presenteeism) (3.2 vs 1.8 days/year) compared with non-smokers. As annual working days varies by age and sex, Australian workforce participation data[@R15] (proportions in full-time and part-time work) were used to calculate sex-specific weighted-average maximum working days in a year among Australians aged 20--69 years. The age-specific and sex-specific productivity indices were then calculated by applying productivity penalties of 0.957 for non-smokers and 0.932 for smokers (calculated from Bunn *et al*,[@R11] as above) to the age-specific workforce participation rates[@R15] (see online [supplementary appendix 2](#SP1){ref-type="supplementary-material"}). Assessment of upper and lower bound estimates for PALYs were drawn from 95% CIs for smoking-related work absences reported by Weng *et al*, which found that current smokers were absent from work for 1.54--3.95 more days per year than non-smokers.[@R16] For these upper and lower estimates, presenteeism data were not varied.

The cost of lost productivity due to smoking was estimated by assignment of a cost for each PALY, which was derived from total Australian gross domestic product (GDP) in 2016 (\$A1 474 705 million)[@R17] divided by the estimated number of equivalent full-time (EFT) Australian workers in 2016 (n=9 411 998).[@R15] The figure for 2016 was \$A157 000.

Results {#s3}
=======

Excess mortality burden attributable to smoking {#s3a}
-----------------------------------------------

Among Australians currently aged 20--69 years who smoke and are followed up until age 70 years, the estimated number of deaths attributable to their smoking was 277261 in males and 129277 in females, equating to 61.7% and 61.8% of the predicted number of total deaths among smoking males and smoking females, respectively ([table 2](#T2){ref-type="table"}). The 406538 excess smoking-attributable deaths represented 23.1% of all deaths predicted to occur among the whole population aged 25--69 years, if followed to age 70 years.

If smoking prevalence in the working age population was half of what it currently is, 203 629 smoking-related deaths could be averted in the working age population if followed to age 70 years ([table 6](#T6){ref-type="table"}). 

###### 

Deaths in Australian smokers and non-smokers over working life

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
                    Deaths in total pop'n status quo   Remainder\       Deaths in smokers status quo   Smoking-attributable deaths   Attributable risk %\*   PAR%†
                                                       alive                                                                                                 
  ----------------- ---------------------------------- ---------------- ------------------------------ ----------------------------- ----------------------- ----------
  Males (years)                                                                                                                                              

   20--24           136 451                            715 367          44 411                         26 618                        59.9                    19.5

   25--29           156 353                            729 037          72 258                         43 473                        60.2                    27.8

   30--34           152 816                            724 059          70 932                         42 905                        60.5                    28.1

   35--39           129 128                            656 542          54 463                         33 158                        60.9                    25.7

   40--44           130 441                            689 502          55 381                         33 962                        61.3                    26.0

   45--49           115 149                            659 230          46 869                         29 045                        62.0                    25.2

   50--54           1 05 325                           663 982          43 557                         27 433                        63.0                    26.0

   55--59           82 686                             631 898          31 991                         20 636                        64.5                    25.0

   60--64           56 286                             576 576          22 826                         15 331                        67.2                    27.2

   65--69           21 981                             548 601          6618                           4700                          71.0                    21.4

  Male total        1 086 616                          6 594 794        449 304                        277 261                       61.7                    25.5

  Females (years)                                                                                                                                            

   20--24           87 016                             720 618          29 806                         17 839                        59.8                    20.5

   25--29           89 793                             783 922          26 327                         15 823                        60.1                    17.6

   30--34           88 471                             785 529          26 110                         15 790                        60.5                    17.8

   35--39           78 008                             712 254          23 058                         14 038                        60.9                    18.0

   40--44           79 715                             755 699          23 709                         14 516                        61.2                    18.2

   45--49           74 523                             714 787          26 261                         16 236                        61.8                    21.8

   50--54           68 467                             720 190          24 626                         15 519                        63.0                    22.7

   55--59           52 076                             684 283          15 419                         9990                          64.8                    19.2

   60--64           38 471                             615 075          11 088                         7488                          67.5                    19.5

   65--69           13 877                             569 100          2855                           2039                          71.4                    14.7

  Female total      670 417                            6 253 823        209 260                        129 277                       61.8                    19.3

  **Total**         **1 757 033**                      **13 656 251**   658 564                        406 538                       **61.7**                **23.1**
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Deaths are n.

\*Attributable risk %=((deaths in smoker population−deaths in non-smoker population)/deaths in smoker population)×100%.

†PAR%=((deaths in smoker population−deaths in non- smoker population)/deaths in total population)×100%.

PAR, population attributable risk.

Years of life lost to smoking {#s3b}
-----------------------------

The estimated years of life lived by the smoking and (hypothetically) non-smoking cohorts are summarised in [table 3](#T3){ref-type="table"}. Overall, it was estimated that smoking at current prevalence reduced the number of years of life lived by 2 227 326 years among males and 914 602 years in females. The total reduction in 3 141 928 years of life lived equated to a 4.2% loss among smokers, and represented a 0.9% loss among the whole population. This equated to 1.2 years of life lost per smoker.

###### 

Years of life (YOL) lived by working age Australians

  Age group         YOL lived by smoking cohort status quo   Total population YOL lived status quo   YOL lost to smoking   \% YOL lost due to smoking status quo   \% YOL lost with 50% reduction in smoking
  ----------------- ---------------------------------------- --------------------------------------- --------------------- --------------------------------------- -------------------------------------------
  Males (years)                                                                                                                                                    
   20--24           6 145 373                                39 307 975                              265 535               4.1                                     2.1
   2 5--29          8 950 587                                36 344 717                              425 928               4.5                                     2.3
   30--34           7 780 771                                31 707 597                              408 948               5.0                                     2.6
   35--39           5 237 777                                24 645 072                              300 038               5.4                                     2.8
   40--44           4 614 212                                21 773 435                              282 121               5.8                                     3.0
   45--49           3 324 052                                16 881 433                              214 886               6.1                                     3.1
   50--54           2 582 922                                13 133 827                              171 223               6.2                                     3.2
   55--59           1 537 322                                8 852 002                               101 095               6.2                                     3.2
   60--64           849 051                                  4 865 887                               50 682                5.6                                     2.9
   65--69           180 374                                  1 680 018                               6870                  3.7                                     1.9
  All males         41 202 441                               199 191 963                             2 227 326             5.1                                     2.6
  Females (years)                                                                                                                                                  
   20--24           6 409 464                                37 795 327                              156 139               2.4                                     1.2
   25--29           5 078 772                                36 593 269                              136 914               2.6                                     1.3
   30--34           4 470 811                                32 294 539                              134 049               2.9                                     1.5
   35--39           3 473 004                                25 322 584                              113 481               3.2                                     1.6
   40--44           3 106 410                                22 683 205                              107 010               3.3                                     1.7
   45--49           2 933 165                                17 567 640                              106 847               3.5                                     1.8
   50--54           2 290 447                                13 741 266                              88 225                3.7                                     1.9
   55--59           1 160 534                                9 302 586                               45 350                3.8                                     1.9
   60--64           638 150                                  5 672 105                               23 559                3.6                                     1.8
   65--69           116 448                                  1 728 512                               3028                  2.5                                     1.3
  All females       29 677 206                               202 701 034                             914 602               3.0                                     1.5
  **Total**         **70 879 647**                           **401 892 998**                         **3 141 928**         **4.2**                                 **2.2**

Data are n or % of years of life lost at current smoking prevalence, or years of life gained (n) with a hypothetical 50% reduction in smoking prevalence across all ages and sex.

Quality-adjusted life years lost to smoking {#s3c}
-------------------------------------------

The estimated QALYs lived by the smoking and (hypothetically) non-smoking cohorts are summarised in [table 4](#T4){ref-type="table"}. Overall, it was estimated that smoking reduced the number of QALYs by 3 849 150 among males and 2 179 623 among females, equating to 2.4 QALYs lost per male smoker and 2.3 QALYs lost per female smoker over the remainder of their working lifetime. The total reduction in 6 028 773 QALYs equated to a 9.4% loss among smokers, and a 2.1% loss among the whole population.

###### 

The impact of smoking on QALYs

  Age group         QALYs smokers status quo   QALYs non-smokers   QALYs lost to smoking   QALYs lost per smoker   \% QALYs lost   QALYs gained with 50% reduction in smoking prevalence
  ----------------- -------------------------- ------------------- ----------------------- ----------------------- --------------- -------------------------------------------------------
  Males (years)                                                                                                                    
   20--24           5 151 031                  29 339 229          520 753                 3.8                     9.2             260 377
   25--29           7 453 501                  24 098 836          795 094                 3.5                     9.6             397 547
   30--34           6 444 321                  20 939 735          722 970                 3.2                     10.1            361 485
   35--39           4 306 803                  16 868 553          506 589                 2.9                     10.5            253 294
   40--44           3 755 848                  14 774 434          459 993                 2.5                     10.9            229 997
   45--49           2 682 939                  11 578 168          339 357                 2.1                     11.2            169 679
   50--54           2 083 241                  8 992 229           264 037                 1.7                     11.2            132 018
   55--59           1 238 278                  6 211 331           153 000                 1.2                     11.0            76 500
   60--64           681 784                    3 382 554           75 875                  0.7                     10.0            37 938
   65--69           144 119                    1 246 204           11 481                  0.2                     7.4             5741
  All males         33 941 864                 137 431 273         3 849 150               2.4                     10.2            1 924 575
  Females (years)                                                                                                                  
   20--24           5 367 135                  27 756 781          439 301                 3.1                     7.6             219 651
   25--29           4 225 511                  27 713 660          361 132                 2.9                     7.9             180 566
   30--34           3 699 805                  24 341 905          328 808                 2.6                     8.2             164 404
   35--39           2 853 714                  18 985 742          262 688                 2.4                     8.4             131 344
   40--44           2 527 472                  16 852 454          238 764                 2.0                     8.6             119 382
   45--49           2 367 114                  12 496 402          228 757                 1.7                     8.8             114 378
   50--54           1 847 075                  9 757 885           179 925                 1.3                     8.9             89 963
   55--59           934 645                    6 913 003           89 209                  0.9                     8.7             44 605
   60--64           512 375                    4 238 671           44 796                  0.5                     8.0             22 398
   65--69           93 042                     1 339 625           6242                    0.2                     6.3             3121
  All females       24 427 888                 150 396 127         2 179 623               2.3                     8.2             1 089 812
  **Total**         **58 369 753**             **287 827 400**     **6 028 773**           **2.4**                 **9.4**         **3 014 386**

Data are n or % of QALY lost at current smoking prevalence, or potential QALY gained (n) with a hypothetical 50% reduction in smoking prevalence across all ages and sex.

QALY, quality-adjusted life years.

Productivity-adjusted life years lost to smoking {#s3d}
------------------------------------------------

The estimated PALYs lived by the population are summarised in [table 5](#T5){ref-type="table"}. Overall, it was estimated that smoking reduced the number of PALYs by 1 711 214  among males and 702 931 among females. The total reduction in 2 475 144 PALYs equated to a 56.0% loss among smokers (with a range of 5.4%--7.1% when upper and lower absenteeism estimates were applied to the model), and a 1.3% loss among the whole population as well as 1.0 PALY lost per smoker, calculated by dividing the total PALYs lost among smokers by the number of smokers in the population at the start of the modelled period.

###### 

The impact of smoking on PALYs in Australian adults over working life

  Age group       PALYs smokers status quo   PALYs non-smokers   PALYs lost to smoking   \% PALYs lost   PALYs lost per smoker   PALYs gained with 50% reduction in smoking prevalence
  --------------- -------------------------- ------------------- ----------------------- --------------- ----------------------- -------------------------------------------------------
  Males (years)                                                                                                                  
   20--24         4 067 800                  22 322 890          247 604                 5.7             1.8                     123 802
   25--29         5 995 490                  18 629 334          380 994                 6.0             1.7                     190 497
   30--34         5 130 166                  15 999 475          346 165                 6.3             1.5                     173 082
   35--39         3 365 515                  12 634 406          239 675                 6.6             1.4                     119 838
   40--44         2 834 059                  10 672 183          211 217                 6.9             1.2                     105 609
   45--49         1 922 042                  7 935 712           149 449                 7.2             0.9                     74 724
   50--54         1 373 426                  5 680 150           109 286                 7.4             0.7                     54 643
   55--59         711 179                    3 433 953           57 992                  7.5             0.4                     28 996
   60--64         324 373                    1 564 574           26 076                  7.4             0.2                     13 038
   65--69         56 387                     481 685             3756                    6.2             0.1                     1878
  All males       25 780 437                 99 354 362          1 772 214               6.4             1.1                     886 107
  Females                                                                                                                        
   20--24         3 040 226                  15 221 816          144 023                 4.5             1.0                     72 012
   25--29         2 401 996                  15 231 600          118 851                 4.7             1.0                     59 426
   30--34         2 076 982                  13 205 345          108 518                 5.0             0.9                     54 259
   35--39         1 579 019                  10 145 572          86 319                  5.2             0.8                     43 160
   40--44         1 376 353                  8 855 322           77 198                  5.3             0.7                     38 599
   45--49         1 246 144                  6 346 512           72 214                  5.5             0.5                     36 107
   50--54         901 028                    4 601 493           54 838                  5.7             0.4                     27 419
   55--59         404 381                    2 905 416           25 928                  6.0             0.3                     12 964
   60--64         199 767                    1 619 124           13 065                  6.1             0.2                     6533
   65--69         36 453                     518 505             1975                    5.1             0.0                     988
  All females     13 262 349                 78 650 706          702 931                 5.0             0.7                     351 465
  **Total**       **39 042 786**             **178 005 069**     **2 475 144**           **6.0**         **1.0**                 **1 237 572**

Data are n or % of PALYs of life lost at current smoking prevalence, or potential PALY gained (n) with a hypothetical 50% reduction in smoking prevalence across all ages and sex.

PALY, productivity-adjusted life years.

As with years of life and QALYs, more PALYs were lost by males, because of their higher smoking prevalence, as well as by people of middle-age, because of the combination of greater smoking prevalence and proportion of people working in these age groups. In women, the highest proportional loss of PALYs occurred in those aged 45--64 years ([table 5](#T5){ref-type="table"}). The highest smoking prevalence among women was observed in the 45--54 years age group ([table 1](#T1){ref-type="table"}), suggesting that interventions to reduce smoking prevalence specifically targeted to this group could be prioritised. Among males, the highest smoking prevalence was observed in the 25--34 years age group ([table 1](#T1){ref-type="table"}), and the potential years of productive life gained through prevention targeting this group might also warrant focus.

Assuming the cost of each PALY is \$A157 000, the total cost of productivity loss attributable to smoking was estimated to be \$A388 billion over the working life of the current Australian population. If a 50% reduction in current smoking prevalence could be achieved, an additional 1 237 572 PALYs, and \$A194 billion in GDP, could potentially be saved ([table 6](#T6){ref-type="table"}), but any savings would need to be offset by the cost of the prevention programme. Even more modest reductions in smoking prevalence (10%) could confer substantial lifetime productivity gains of \>\$A38 billion ([table 6](#T6){ref-type="table"}).

###### 

Effect of proportional reductions in smoking prevalence on working lifetime national productive capacity among the Australian adult population of 2015

  -------------------------------------------------------------------------------------------------------
  Smoking prevalence reduction (%)   Deaths averted   QALYs gained   PALYs gained   Value of PALY gain\
                                                                                    (\$A billion)
  ---------------------------------- ---------------- -------------- -------------- ---------------------
  10↓                                40 644           602 877        247 514        38.8

  25↓                                101 635          1 507 193      618 786        97.0

  50↓                                203 269          3 014 386      1 237 572      193.9

  75↓                                304 904          4 521 580      1 856 358      290.9

  90↓                                365 884          5 425 896      2 227 630      349.0
  -------------------------------------------------------------------------------------------------------

Data are n or value (\$A of productivity gain) across a variety of hypothetical reductions in smoking prevalence (assumed to occur across all age groups and in both sexes).

PALY,  productivity-adjusted life years; QALY,  quality-adjusted life years.

Discussion {#s4}
==========

The findings of our study highlight the substantial impact of smoking on health and productivity in the Australian population. Among Australians currently aged 20--69 years who are followed up to age 70 years, smoking was predicted to result in an excess of over 400 000 deaths, with a loss of \>3 million years of life over the productive working age of current Australian smokers, and a 6% loss of PALYs, equating to \$A388 billion lost in GDP.

Productivity losses accrued from a combination of premature mortality, morbidity-associated work absences (absenteeism) and reductions in productive capacity while at work (presenteeism). In our analyses, males and females who smoke were estimated to experience an almost threefold increase in the risk of death compared with people who do not smoke. This result is comparable to a study in 2015 on an Australian cohort population by Banks *et al*, which estimated smoking increases mortality around twofold to fourfold in current smokers.[@R18] Our study estimated that current rates of smoking would cause \>3 million years of life lost among 2.5 million Australian smokers aged 20--69 years when followed up until age 70 years. The 1997 Australian National Tobacco Campaign was estimated to have led to 190 000 people (of all ages) quitting smoking, and a gain of 323 000 years of life with follow-up until 85 years.[@R19] Hence, each quitter gained 1.7 years of life until age 85 years. This estimate is in accord with our estimate of 1.2 years of life lost per smoker followed up for an overall shorter period of time from 20 to 69 years to 70 years.

In our study, the years of life lost was lower among females, due to a lower prevalence of smoking. As expected, years of life lost to smoking was also higher among younger age groups, because of higher smoking prevalence (particularly among men) and follow-up time within the modelled period.

Smoking is well known to decrease life expectancy. A study capturing 50 years of observation of male British doctors by Doll *et al* suggested that male smokers died on average 10 years earlier compared with non-smokers.[@R20] A study in Chinese adults estimated smokers at age 35 years lost around 3 years of life when compared with people who never smoked,[@R21] while in a Norwegian population it was estimated that 1.4--2.7 years of life were lost in heavy smokers aged 40--70 years.[@R22] A recent study modelling average life expectancy in the Australian population by Mannan *et al* found that reducing the prevalence of smoking among Australian smokers to 10% would increase the life expectancy by 0.4--2 years for males and 0.7--2 years for females.[@R23]

Our study estimated that smoking would cause a loss of over 2.4 million PALYs among Australians currently aged 20--69 years who smoke, if followed up until age 70 years. This equated to 1.0 PALY lost per smoker. This compares with the loss of 1.4 PALYs per working age person with diabetes over a similar time horizon.[@R8] The differences are attributable to a higher prevalence of diabetes than smoking and a greater reduction in productivity conferred by diabetes than smoking. Of course, this does not mean greater priority should be given to prevention of diabetes, which is more difficult to achieve given its multiplicity of risk factors, chief among which is genetic.

The loss of productivity, measured in terms of PALYs, among the working population has economic implications. Our study is the first to examine this cost in terms of PALYs, but previous studies have estimated the cost of productivity loss due to smoking via other means. In a study on the Australian population by Collins and Lapsley, it was estimated that smoking caused a loss of \$A4.9 billion due to presenteeism (0.5% of GDP) and \$A779 million due to absenteeism (0.08% of GDP) in the single financial year of 2004/2005.[@R6] In 2000, Lightwood *et al* reported that the total economic costs of smoking, including productivity losses, amounted to 2.1%--3.4% of GDP in Australia.[@R24] A study in Thailand reported that the economic burden of smoking was 0.8% of country GDP, while the revenue from tobacco industry only contributed to 0.5% of the total GDP.[@R25] The results of our study are not directly comparable to those of other studies because of the differences in evaluation time horizons, which varied from 1 to 50 years in our study (depending on the age of the smokers), and which for other studies was limited to a single year. We had also adopted a simple 'top-down' approach to allocating total GDP to EFT worker. Nonetheless, our conclusion is the same as that of the other studies; that smoking imposes a large economic burden on productivity.

It is therefore clear that prevention of smoking is important from an economic standpoint. The high indirect costs of smoking suggest that it would be better for policy makers to consider the amount of money spent on prevention strategies as an 'investment' rather than as an 'expenditure'.

Our study did not address the issue of smoking cessation. Rather, it sought to provide a conceptual illustration of the productivity losses due to smoking by assuming hypothetically that it did not exist, that is, smoking was not taken up in the first place. It should be acknowledged that this is a hypothetical scenario, and in reality, smoking cessation interventions as well as interventions or policy settings dissuading smoking uptake, would be required to aim for the productivity gains modelled herein, even those projected from more modest reductions in smoking prevalence. Smoking cessation is beneficial to productivity. A recent study in Japan suggested that smoking cessation improved productivity at work, with the productivity and associated costs of former smokers being similar to those who never smoked.[@R26] This finding is supported by the findings of Baker *et al*, who found no significant difference between former and never smokers in term of productivity loss in China, the US and Europe.[@R27] A 19-year follow-up study among males in Finland by Kiiskinen *et al* also stated that quitting smoking could avert almost 60% of losses due to the direct and indirect costs of smoking.[@R28]

Our study is the first to examine the impact of smoking on productivity in terms of PALYs, a novel and informative measure. Our method uses readily available data to estimate the macroeconomic productivity impact of smoking in a methodologically accessible manner, which could be applied in a variety of other country settings or risk/disease burdens. Further research using PALYs provides the opportunity to compare the effects of different tobacco control measures across various age, sex and employment settings, which can inform the targeting of interventions. In addition, application of this method across countries would provide a greater understanding of the regional and global indirect costs of smoking, and the potential productivity gains from tobacco control. Quantifying burden of disease in terms of PALYs can inform resource allocation and decision making for public and workplace health strategies, and may assist in leveraging employer engagement with tobacco control programmes.

PALYs are like QALYs because they 'penalise' time spent alive by people affected by a disease or condition, and do so in the same manner---by proportionally adjusting time according to the relative extent to which productivity (PALYs) or quality of life (QALYs) is affected by that disease or condition. QALYs have limitations that stem from their attempting to quantify the highly subjective nature of quality of life and how much people value it,[@R29] but despite these limitations, they remain important measures of burden of disease that help inform healthcare planning. Furthermore, healthcare decision making does not rely on QALYs alone; many other factors need to be taken into consideration. As discussed, we feel that the impact of ill health on productivity should be among these factors, and PALYs offer a convenient method for measuring this. One advantage that PALYs have over QALYs is that the measurement and concept of productivity loss is much more objective than the the measurement and concept of quality of life.

Several limitations of our study warrant mention. First, our analyses did not take into account healthcare costs devoted to managing smoking-related ill health, which were estimated to be \$A318 million in the year 2004/2005 (offset for savings accrued through premature mortality).[@R6] Furthermore, potential gains from reductions in passive smoking-related mortality and morbidity, and productivity losses associated with family members caring for those with disabling smoking-related morbidity were also excluded. On the other hand, we did not consider the economic activity associated with production and sale of tobacco products, all of which contribute to GDP, nor government revenue generated from tobacco taxes.

Second, life table modelling is a simple and commonly used tool used in epidemiological and demographical studies, but has established limitations. It was assumed that age-specific mortality did not change over time (this is a well-known limitation called the 'life table assumption'). However, as the relative impact of smoking is unlikely to change substantially, and the life table assumption was applied to both smokers and non-smokers, this would not have significantly impacted the conclusion that smoking imposes a significant burden on health and productivity. The third limitation stemmed from the assumption that there was no uptake nor cessation of smoking over time within the modelled scenarios. Furthermore, the utility values and productivity indices used in this study were potentially imprecise, as they were not stratified for type of work. The impact of smoking on productivity is likely to differ across different types of jobs, and socioeconomic status. Similarly, assessment of the quality of life differences between smokers and non-smokers (from which QALYs are calculated) can vary by instrument,[@R32] and is also potentially confounded by socioeconomic factors such as educational attainment, household income and occupation.[@R33] We could not account for the duration of smoking among smokers, nor any socioeconomic differences between smokers and non-smokers, and other factors that may confound the association between smoking and utilities and productivity indices.

Fourth, like QALYs, PALYs are imprecise because they attempt to measure entities that are difficult to measure. Nevertheless, even with highly conservative assumptions regarding the effect of smoking on productivity among individuals, the collective impact is large. And perhaps the imperfections of PALYs will help stir debate, as QALYs initially did 40 years ago,[@R34] which in turn will progress the science, economics, art and politics of health-related productivity.

Lastly, in terms of estimating impact on GDP, the present study assumed that all individuals and jobs contributed equally to GDP, which is not the case, and we assumed throughout the simulated follow-up, GDP would be stable, rather than increase. This last assumption would have led to an underestimation of the economic impact of smoking.

The findings of our study provide an important and novel assessment of the burden of smoking on the Australian population. They highlight the importance of preventing smoking, strategies for which, if effective, are very likely to be cost-effective, and possibly even cost-saving, in the long term.[@R35] This issue is even more telling for populations within which the prevalence of smoking is very high, and those low-income and middle-income countries for whom the burden of productivity loss may be considerable, such as Indonesia, a close neighbour to Australia, for which smoking prevalence rates among men is as high as 65%.[@R36] Future studies may also consider the type of jobs in the 'working' population when calculating productivity loss, as prevalence rates of smoking, and salaries/GDP per worker may differ, and smoking has been shown to be socioeconomically patterned.[@R37]

Conclusion {#s5}
==========

Smoking imposes a very significant burden on the larger economy of Australia, despite that it is a country with a relatively low prevalence of smoking. Potential productivity gains for Australia with expansion of tobacco control measures are compelling. The likely economic benefits arising from productivity gains mean that greater investment in reducing the uptake of smoking is warranted.

###### What this paper adds

-   Direct healthcare costs attributable to smoking are only a proportion of the economic burden imposed by tobacco.

-   This study uses the novel concept of 'productivity-adjusted life years' (PALYs) to estimate the macroeconomic costs of smoking, and potential gains from smoking cessation.

-   Following the current Australian smoking population to the age of 70 years, 2.4 million PALYs would be lost to smoking.

-   Assuming that each PALY in Australia is equivalent to \$A157 000 (gross domestic product per equivalent full-time worker in 2016), the economic impact of lost productivity over the working lifetime of current Australian smokers would amount to \$A388 billion.
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